Orchestra Bio Acquisition: What OpenAI Bought and Why It Matters for AI Drug Development
The Orchestra Bio acquisition is OpenAI’s purchase of a four-year-old AI startup whose software agents help drug companies manage development
Orchestra Bio Acquisition